MEK1, Unactive (M02-14BG)
|
|
|
Catalog Number |
Pack Size |
Price (USD) |
|
|
| MEK1, Unactive |
M02-14BG-20 |
20 ug |
$195 40% OFF |
|
Add to Cart |
| MEK1, Unactive |
M02-14BG-50 |
50 ug |
$395 40% OFF |
|
Add to Cart |
| MEK1, Unactive |
M02-14BG-BULK |
BULK |
CONTACT US |
|
|
|
|
* Prices listed in the "shopping cart" are not discount inclusive. Promotional Prices will be applied internally during the processing of orders and net totals adjusted accordingly.
Description: Recombinant full-length human MEK1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
| Tag: |
GST tag |
| Expression System: |
Sf9 insect cells using baculovirus |
| Species: |
Human |
| Sequence: |
Full length |
| Genbank Number: |
NM_002755
|
| |
|
Storage, Stability, and Shipping: Store product at –70
oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Applications: Kinase Assay, Western Blot
Molecular Weight: ~71 kDa
Gene Aliases : MAP2K1; MKK1; MAPKK1; PRKMK1
Scientific Background: MEK1 is a protein serine/threonine kinase that is an upstream activator of the extracellular signal-regulated kinases (ERKs) which are activated in response to numerous growth factors and cytokines (1). Activation of ERKs by MEK1 involves phosphorylation of both tyrosine and threonine residues. MEK1, like the ERKs is ubiquitously distributed in tissues with the highest expression in heart, brain and spinal cord. MEK plays an important role in the growth and survival of cancer cells. In hepatocellular carcinoma, MEK activity is frequently elevated and inhibitors of MEK activity may be an effective treatment for this disease (2).
References:
1. Sugden, P H. et al: Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 1997 Aug; 9(5):337-51.
2. Huynh, H. et al: Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
BMC Gastroenterol. 2003 Aug 8; 3:19.
gel.gif) |
|
Purity: Sample Purity Data. For specific information on a given lot, see related technical data sheet. |
MEK1, Unactive Research Areas
The MEK1, Unactive product can be utilized in the following research areas, but not limited to:
Apoptosis/Autophagy, Cancer, Cardiovascular Disease, ERK/MAPK Pathway, Invasion/Metastasis, Neurobiology, Ser/Thr Kinases
| Product Type |
Product Name |
Catalog Number |
Application |
Pack Sizes |
| Enzymes |
MEK1, Active |
M02-10G |
Kinase Assay, Western Blot |
View MEK1, Active
|
| Antibodies |
Anti-MEK1 |
M02-60M |
WB, IP |
View Anti-MEK1
|
| Enzymes |
MEK1 (EE), Active |
M02-12G |
Kinase Assay, Western Blot |
View MEK1 (EE), Active
|
| Signaling Proteins |
MEK1, Unactive |
M02-14H |
Kinase Assay, Western Blot |
View MEK1, Unactive
|
| Antibodies |
Anti-MEK1/2 |
M02-63R |
WB |
View Anti-MEK1/2
|
| Signaling Reagents |
MEK1 (K97A), Unactive |
M02-16H |
Kinase Assay, Western Blot |
View MEK1 (K97A), Unactive
|